首页> 美国卫生研究院文献>Infection and Immunity >ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin.
【2h】

ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin.

机译:百日咳毒素的催化S-1亚基中的ADP-核糖基转移酶突变。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The ADP-ribosyltransferase activity of pertussis toxin resides within the S-1 subunit of the toxin. Deletion mapping of a recombinant S-1 subunit produced in Escherichia coli showed that amino acids 2 through 180 are required for ADP-ribosylation of Gi protein. Mutants of the S-1 subunit which lacked either amino acids 2 through 22 or amino acids 153 through 180 failed to express enzyme activity, implicating a functional or structural role for these residues in catalysis. The catalytic carboxy-terminal S-1 deletion, C-180, was found to be more soluble than the recombinant S-1 subunit, making it a useful construct for future structure-function studies on enzyme catalysis. Four independent single-amino-acid substitutions which decreased ADP-ribosyltransferase activity were constructed in the recombinant S-1 subunit. Substitution of Asp-11 by Ser, Arg-13 by Leu, or Trp-26 by Ile decreased enzyme activity to below detectable levels (less than 1.0% of that of the recombinant S-1 subunit). The Glu-139-to-Ser substitution reduced ADP-ribosyltransferase activity to 15% of that of the recombinant S-1 subunit. Both the oxidized and reduced forms of the recombinant S-1 subunit and recombinant S-1 subunits containing single-amino-acid substitutions were degraded through identical immunoreactive tryptic peptides, suggesting that the conformations of the mutants are similar to that of the recombinant S-1 subunit. Identification of noncatalytic forms of the S-1 subunit of pertussis toxin which have conserved protein structure is an initial step in the generation of a recombinant noncatalytic form of pertussis toxin which may be tested as a candidate for an acellular vaccine against Bordetella pertussis.
机译:百日咳毒素的ADP-核糖基转移酶活性位于毒素的S-1亚基内。大肠杆菌中产生的重组S-1亚基的缺失图谱显示,Gi蛋白的ADP-核糖基化需要2至180位氨基酸。缺少氨基酸2至22或氨基酸153至180的S-1亚基突变体无法表达酶活性,这暗示了这些残基在催化中的功能或结构作用。发现羧基端S-1的催化缺失C-180比重组S-1亚基更可溶,使其成为酶催化未来结构功能研究的有用构建物。在重组S-1亚基中构建了四个降低ADP-核糖基转移酶活性的独立的单氨基酸取代。用Ser取代Asp-11,用Leu取代Arg-13或用Ile取代Trp-26,使酶活性降至可检测的水平以下(不到重组S-1亚基的1.0%)。 Glu-139-Ser取代将ADP-核糖基转移酶活性降低到重组S-1亚基的15%。重组S-1亚基和含有单个氨基酸取代的重组S-1亚基的氧化形式和还原形式均通过相同的免疫反应性胰蛋白酶肽降解,这表明突变体的构象与重组S- 1个亚基。鉴定具有保守蛋白质结构的百日咳毒素的S-1亚单位的非催化形式是产生百日咳毒素的重组非催化形式的第一步,该重组非催化形式的百日咳毒素可以作为针对百日咳博德特氏菌的脱细胞疫苗的候选物进行测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号